CN103561748A - 治疗眼疲劳的方法 - Google Patents

治疗眼疲劳的方法 Download PDF

Info

Publication number
CN103561748A
CN103561748A CN201280027412.3A CN201280027412A CN103561748A CN 103561748 A CN103561748 A CN 103561748A CN 201280027412 A CN201280027412 A CN 201280027412A CN 103561748 A CN103561748 A CN 103561748A
Authority
CN
China
Prior art keywords
hydroxy
alkyl
fatty acid
hydrogen
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201280027412.3A
Other languages
English (en)
Chinese (zh)
Inventor
上野隆司
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sucampo GmbH
Original Assignee
Sucampo GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sucampo GmbH filed Critical Sucampo GmbH
Publication of CN103561748A publication Critical patent/CN103561748A/zh
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/10—Ophthalmic agents for accommodation disorders, e.g. myopia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CN201280027412.3A 2011-04-07 2012-04-06 治疗眼疲劳的方法 Pending CN103561748A (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161472875P 2011-04-07 2011-04-07
US61/472,875 2011-04-07
PCT/JP2012/060094 WO2012137987A1 (en) 2011-04-07 2012-04-06 Method for treating asthenopia

Publications (1)

Publication Number Publication Date
CN103561748A true CN103561748A (zh) 2014-02-05

Family

ID=46966570

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201280027412.3A Pending CN103561748A (zh) 2011-04-07 2012-04-06 治疗眼疲劳的方法

Country Status (8)

Country Link
US (1) US8889735B2 (enExample)
EP (1) EP2694077A4 (enExample)
JP (1) JP2014510022A (enExample)
KR (1) KR20140035363A (enExample)
CN (1) CN103561748A (enExample)
CA (1) CA2830626A1 (enExample)
TW (1) TW201247206A (enExample)
WO (1) WO2012137987A1 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014159679A1 (en) 2013-03-12 2014-10-02 The United States Of America, As Represented By The Secretary, Department Of Health & Human Services Methods for using lubiprostone to absorb fluid from the subretinal space
MA42953A (fr) 2015-09-22 2018-08-01 Graybug Vision Inc Composés et compositions pour le traitement de troubles oculaires
WO2018175922A1 (en) 2017-03-23 2018-09-27 Graybug Vision, Inc. Drugs and compositions for the treatment of ocular disorders
CN111201040A (zh) 2017-05-10 2020-05-26 灰色视觉公司 用于医学疗法的缓释微粒及其悬浮液

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140057A (zh) * 1995-03-10 1997-01-15 株式会社·R-技术上野 前列腺烷酸化合物治疗视神经障碍
CN1575178A (zh) * 2001-08-23 2005-02-02 苏坎波公司 治疗眼压过高和青光眼的方法和组合物
WO2008023784A1 (fr) * 2006-08-25 2008-02-28 Showa University Agent pour l'amélioration d'un trouble de la circulation ophtalmique
CN101917986A (zh) * 2007-12-24 2010-12-15 麦仁斯有限公司 用于治疗和预防青光眼的药物组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5380709A (en) 1987-01-28 1995-01-10 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
US5166174A (en) 1987-01-28 1992-11-24 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti-ulcers containing same
US5225439A (en) 1987-01-28 1993-07-06 K.K. Ueno Seiyaku Oyo Kenkyujo Prostaglandins E and anti ulcers containing same
CA1322749C (en) 1987-01-28 1993-10-05 Ryuzo Ueno Prostaglandins of the d series, and tranquilizers and soporifics containing the same
CA1324129C (en) 1987-04-30 1993-11-09 Ryuzo Ueno Prostaglandins of the f series
US5221763A (en) 1987-04-30 1993-06-22 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5591887A (en) 1987-04-30 1997-01-07 R-Tech Ueno, Ltd. Prostaglandins of the F series
US5236907A (en) 1988-10-01 1993-08-17 R-Tech Ueno Ltd. Ocular hypotensive agents
DE3850676T2 (de) 1987-09-18 1994-11-03 Ueno Seiyaku Oyo Kenkyujo Kk Hypotensive okulare Mittel.
US5151444B1 (en) 1987-09-18 1999-07-06 R Tech Ueno Ltd Ocular hypotensive agents
US5166178B1 (en) 1987-09-18 1998-07-21 R Tech Ueno Ltd Ocular hypotensive agents
US5194429A (en) 1988-10-01 1993-03-16 K.K. Ueno Seiyaku Oyo Kenkyujo Ocular hypotensive agents
TW249226B (enExample) 1990-04-04 1995-06-11 Aderk Ueno Kk
US5221690A (en) 1991-10-02 1993-06-22 R-Tech Ueno Ltd. Increasing the choroidal blood flow
CA2150287C (en) 1994-06-03 2004-08-10 Ryuji Ueno Agent for treating hepato-biliary diseases
JP3625946B2 (ja) * 1995-03-10 2005-03-02 株式会社アールテック・ウエノ 視神経障害改善剤
CN102126998B (zh) 1996-06-10 2013-06-12 苏坎波公司 内皮素拮抗剂
US6291466B1 (en) * 1998-07-30 2001-09-18 Allergan Sales, Inc. Cholinergic agents in the treatment of presbyopia
SE0002211D0 (sv) * 2000-06-13 2000-06-13 Synphora Ab Methods and compositions for prevention of myopia

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1140057A (zh) * 1995-03-10 1997-01-15 株式会社·R-技术上野 前列腺烷酸化合物治疗视神经障碍
CN1575178A (zh) * 2001-08-23 2005-02-02 苏坎波公司 治疗眼压过高和青光眼的方法和组合物
WO2008023784A1 (fr) * 2006-08-25 2008-02-28 Showa University Agent pour l'amélioration d'un trouble de la circulation ophtalmique
CN101917986A (zh) * 2007-12-24 2010-12-15 麦仁斯有限公司 用于治疗和预防青光眼的药物组合物

Also Published As

Publication number Publication date
EP2694077A4 (en) 2015-01-21
JP2014510022A (ja) 2014-04-24
US8889735B2 (en) 2014-11-18
CA2830626A1 (en) 2012-10-11
KR20140035363A (ko) 2014-03-21
TW201247206A (en) 2012-12-01
WO2012137987A1 (en) 2012-10-11
US20120259008A1 (en) 2012-10-11
EP2694077A1 (en) 2014-02-12

Similar Documents

Publication Publication Date Title
JP5686819B2 (ja) 黄斑浮腫を処置するための医薬組成物
CN101400354B (zh) 水性组合物
US8889735B2 (en) Method for treating asthenopia
US20140066506A1 (en) Method for treating macular degeneration
US20050014837A1 (en) Method for treating ocular hypertension and glaucoma
JP2004538306A (ja) 高眼圧症および緑内障の処置
US20030060511A1 (en) Method for treatment of ocular hypertension and glaucoma
WO2003082257A2 (en) Method for treating ocular hypertension and glaucoma
AU2002255346A1 (en) Method for treatingocular hypertension and glaucoma
HK1181675A (en) Pharmaceutical composition for treating macular edema
AU2002326160A1 (en) Method and composition for treatment of ocular hypertension and glaucoma

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20140205